Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity.
「雙胰島素依賴性胰島素促分泌肽/葡萄糖樣肽-1 受體激動劑對肥胖者體重減輕的影響」。
Front Endocrinol (Lausanne) 2023-03-14
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects.
Tirzepatide對2型糖尿病患者和非患者的體重減輕效果:功效和不良反應回顧。
Patient Prefer Adherence 2024-02-15
Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity.
Tirzepatide:一種新型心血管保護劑在第2型糖尿病和肥胖症中。
Curr Probl Cardiol 2024-04-02
Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence.
Tirzepatide對抗肥胖和胰島素抵抗:病理生理學方面和臨床證據。
Front Endocrinol (Lausanne) 2024-07-09
Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management.
Tirzepatide:揭開雙重靶向糖尿病和肥胖管理的新曙光。
Expert Rev Endocrinol Metab 2024-08-28